Abstract
PCR104 How Do Chinese Draft Guidelines (2021) on Patient Focused Drug Development Compare with Those of EMA and FDA?
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have